𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon gamma as a potential therapy for Friedreich ataxia

✍ Scribed by Tomassini, B.; Arcuri, G.; Fortuni, S.; Sandi, C.; Ezzatizadeh, V.; Casali, C.; Condo, I.; Malisan, F.; Al-Mahdawi, S.; Pook, M.; Testi, R.


Book ID
123441489
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
63 KB
Volume
333
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A Potential New Therapeutic Approach for
✍ Chapdelaine, Pierre; Coulombe, ZoΓ©; Chikh, Amina; GΓ©rard, Catherine; Tremblay, J πŸ“‚ Article πŸ“… 2013 πŸ› Nature Publishing Group 🌐 English βš– 639 KB

TALEs targeting a promoter sequence and fused with a transcription activation domain (TAD) may be used to specifically induce the expression of a gene as a potential treatment for haploinsufficiency. This potential therapeutic approach was applied to increase the expression of frataxin in fibroblast

Interferon-gamma (IFN-Ξ³) as a potential
✍ Gardner, Renee V. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 41 KB

Interferons (IFN) have had increasing clinical usage in the treatment of a variety of disorders, at times being used in combination with chemo-or radiotherapy. However, interferons may have inhibitory effects on hematopoietic stem cell proliferation and the effects of this cytokine's use on long-ter

Upregulation of expression from the FRDA
✍ Joseph P. Sarsero; Lingli Li; Hady Wardan; Karin Sitte; Robert Williamson; Panos πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 294 KB

## Abstract ## Background Friedreich ataxia is a slowly progressive neurodegenerative disease caused by reduced expression of frataxin as a result of a GAA repeat expansion in the first intron of the __FRDA__ gene. We report here the development of a sensitive cellular assay for frataxin expressio